Objective: Managing symptomatic chronic type B aortic dissection (SCTBAD) by the Streamliner Multilayer Flow Modulator (SMFM) stent (Cardiatis, Isnes, Belgium) is akin to provisional structural support to induce complete attachment of the dissection flap, but with the ability of aortic remolding. This study investigated the SMFM's capability to enact healing of SCTBAD.
Endovascular aortic therapy for symptomatic chronic type B aortic dissection (SCTBAD) is justified in patients with rapid aortic expansion (>1 cm/y) and a maximum thoracic aortic diameter >5.5 cm. 1 The aim of the therapy is to stop aortic expansion by eliminating the flow supply to the false lumen. 2 The treatment of SCTBAD with the currently available stent grafts was found to have a low 30-day mortality rate of 3.2%; the most common early complication is early endoleak, reported to be 11.1%. 3 Although the early outcomes look favorable, the midterm outcomes (30 days to 5 years) show that up to 20% of patients required reintervention for established or imminent rupture. 4 This is attributed to the aortic dilation caused by the reported proximal type I endoleaks (8.1%). 4 The overall reported midterm mortality was 9.2%. 4 The associated aneurysmal degeneration progress in type B aortic dissections is a poorly understood phenomenon, highly influenced by local hemodynamics. 5, 6 Computational techniques were used to assess the blood flow in type B dissections. Patients with rapid aneurysmal expansion and stable aneurysms were studied. 7 Studies predicted increased flow within the dissection false lumens compared with stable aneurysms. Wan et al 8 computationally assessed and predicted the location of thrombus formation in dissections, 8 identifying the presence of vortical structures in the false lumen, over the whole cardiac cycle, which is believed to trigger platelet activation. The aortic morphology and primary entry tear size and position are believed to exert significant effects on flow and other hemodynamic parameters as blood flow increases into the false lumen with increasing tear size and proximal location. 9 A new stent technology that induces flow modulation along the full aorta was recently brought to the attention of the endovascular world, the Streamliner Multilayer Flow Modulator (SMFM) stent (Cardiatis, Isnes, Belgium).
The application of the SMFM in treating SCTBAD is less known in regard to this technology's potential to manage chronic dissections. It was reported that this device instigates the process of aortic remodeling and patent branch perfusion after implantation. 10 In this study, we employ the power of the computational fluid dynamics (CFD) technique to gain more information on how the SMFM changes the local hemodynamics of 12 complicated SCTBADs and what effects those changes manifest on the aortic branch patency.
METHODS
Patient data. Clinical data comprising preoperative and postoperative treatments of SCTBAD were obtained from a multicenter database hosted by the Multilayer Flow Modulator (MFM) Global Registry, Ireland (Table I) . The registry data were entered by the implanting physicians on invitation to collaborate, through the existing online platform, or by qualified full-time registry employees, in the form received from the hospitals. The MFM Global Registry allowed all submitted cases to be analyzed in a nonconsecutive entry order and classified in groups and subgroups to inform the vascular community about the modulation technology. All cases were done under individual patient consent and institutional ethical approval in continental Europe and North Africa and submitted to MFM Global Registry. These patients were declined for current endovascular techniques because of anatomic complexity and high-risk status.
All cases (mean age, 59.6 6 16 years) presented with compressed true lumen and a mean dissection length of 30.23 6 13.3 cm (Table II) . No paraplegia, renal failure, or stroke was reported. Cases 1 to 7 were treated with only the SMFM (primary intervention); cases 8 to 11 had a previous intervention with a stent graft, whereas one case (No. 12) had a previous SMFM repair, which wasn't successful due to the proximal foreshortening of the SMFM device from zone 3 to zone 4. The secondary intervention with the SMFM fixed this problem. The cases 8 to 11 had a secondary SMFM repair as a provisional extension to induce complete attachment (PETTICOAT) technique. Table I shows the aortic segments covered by the SMFM following the principle that the aorta has to be covered from normal proximal healthy to normal distal healthy aorta, for at least 3 cm in each direction. The postoperative data were analyzed at 1-year follow-up. The false lumen index (FLI) was calculated as a ratio between the false lumen and true lumen volumes, which were measured using the 3mensio package (Pie Medical  Imaging [PMI] , Maastricht, The Netherlands).
Preoperative and postoperative aortic dissection reconstruction. All medical images were obtained by computed tomography and saved in Digital Imaging and Communications in Medicine format with a slice thickness and a pixel size ranging from 0.7 to 2 mm and 0.54 to 0.97 mm, respectively. A semiautomatic segmentation protocol within Mimics (v17.0; Materialise, Leuven, Belgium) was used to extract the threedimensional preoperative and postoperative aortic false and true lumens (Fig 1) , enclosed by triangulated fitted surfaces (case 1; Fig 2, A) .
Reconstructing SMFM geometry. Because of the poor resolution of computed tomography scans, it was not possible to reconstruct the SMFM stent mesh as the mesh wire diameter of the SMFM is smaller than 0.4 mm, which resulted in a pixilated region on computed tomography. Instead, the interlaced geometry was generated numerically and fitted along the extracted device's normal diameters by employing the Frenet-Serret frame to define a local coordinate system, along the threedimensional centerline of each device (Fig 2, B) , using a MATLAB (MathWorks, Natick, Mass) code developed in-house.
Modeling the blood hemodynamics. CFD techniques were employed to model the blood hemodynamics for the selected cases. This is a branch of fluid mechanics that uses numerical analysis and algorithms to solve and analyze problems related to fluid flows. The interaction between a fluid and a surface can be predicted by solving the fluid flow differential equations associated with the boundary conditions. The fluid domains (ie, blood volume) for all cases were meshed within the ICEM software (ANSYS ICEM CFD v15.0; ANSYS, Canonsburg, Pa) as shown in Fig 2, C. One to six million tetrahedral elements were used to capture the complexity of the SCTBAD and stent geometries for the preoperative and postoperative cases. The Navier-Stokes equations of pulsatile blood motion were solved numerically using the commercially available ANSYS Workbench 15.0 package (ANSYS CFX solver), by the coupled algebraic multigrid approach, with finite volume domain discretization. At the aortic valve inlet, a realistic resting flow rate waveform (Fig 2, D ) was applied; a resting pressure waveform (Fig 2, D) was defined at the arch outlets. 11, 12 A no-slip boundary condition was assigned at the SMFM device struts and the aortic wall.
The fluid was modeled as incompressible, nonnewtonian, and homogeneous with a density of 1050 kg/m 3 and a dynamic viscosity described by the Carreau-Yasuda model (Equation 1) for blood shearthinning behavior passing through the stent filament.
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( 1) where g d denotes the scalar shear rate. The CarreauYasuda parameters, viscosities m 0 and m N (lower and upper ends of the shear rate range) and l, n, a, for the transition between these extreme conditions at 37 C are shown in Table III . 15 Five cardiac cycles were required to achieve pulse cycle independence, with a time step size of 0.01 second. Rigid wall and laminar flow boundary conditions were assigned to all models. Mesh independence was achieved when changes in the outlet maximum velocity measurements were <2% between successive meshes. The criteria for mass and momentum residuals used were 1 Â 10 À4 and 1 Â 10 À6 , respectively, to enforce convergence. Five cardiac cycles were simulated to ensure the decay of initial transients, and the results are reported from the fifth cycle. The calculations required to simulate the interaction of blood, aortic wall, and SMFM stents were performed with a highspeed computer (64-bit MSI mobile workstation, CPU: Intel Core i7, eight core 3.67GHz with 32GB of RAM). The time for one simulation took 170 hours because the computer had to solve >6 million equations per iteration for pulsatile flow motion, multiplied to 500 iterations (5 cycles) as 1 cycle has 100 time steps. The distribution of blood flow into the true and false lumens, aortic branch perfusion, and aortic wall pressure were calculated using the ANSYS postprocessor module.
Statistics. Statistical analysis was performed using MiniTab 17.1.0 (Minitab Inc, State College, Pa), employing the Mann-Whitney test. A P value of <.05 was deemed to be statistically significant. The study results are presented as mean 6 standard deviation. The 12 cases were divided into three subgroups based on the anatomy of the type B dissection, the dissection entry tear location, and the thoracic endovascular aortic repair (TEVAR) technique used, as follows: subgroup 1: straight (cases 2, 4-7, and 9), aortouni-iliac (cases 8, 11, and 12), and aortobi-iliac (cases 1, 3, and 10); subgroup 2: ascending (case 4), transverse (cases 3, 6, 9, and 11), and descending (cases 1, 2, 5, 7, 8, 10, 12) aorta; and subgroup 3: PETTICOAT (cases 8-11) and normal (stent grafts used, cases 1-7 and SFM, case 12). 
RESULTS
Anatomic changes were noticed at 1-year follow-up for all cases. In most of the cases, the whole length of the SCTBADs was full of entry and exit holes, from the true to false lumen, ranging from one to three holes (cases 1, 5-7, 11, and 12) to six holes (case 2-4, 8, and 10). Anatomic parameters of the SCTBAD, such as the dissection length, maximum aortic diameter, and true lumen and false lumen volumes, were monitored and compared between the preoperative and postoperative states for the 12 cases (Table II) .
The mean total dissection length before treatment was 30.23 6 13.25 cm; after treatment, it decreased to 21.41 6 13.18 cm, as false lumen thrombosis was not counted. The mean maximum aortic diameter increased from 5.93 6 1.46 cm (preoperative state) to 6.39 6 1.98 cm (postoperative state). The mean true lumen volume The preoperative and postoperative mean FLI (Table II) was 0.29 6 0.13 and 0.21 6 0.15, respectively, with the associated 95% confidence intervals of 0.20 to 0.37 for the preoperative state and 0.11 to 0.31 for the postoperative state. Fig 3, A shows the plot of the FLI for both states. The mean FLI was not statistically different between the preoperative and postoperative states as the confidence intervals are overlapped. Across the 12 cases, the FLI dropped, as shown in Fig 3, B . Overall, the mean true lumen gain for the cohort, at minimum 1-year follow-up, had increased to 25% (Fig 3, C) . Cases 1 and 6 recorded the largest true lumen gain of 92% and 68%, respectively, whereas the majority (cases 4, 5, and 8-12) had a gain in the range of 16% to 40%.The false lumen volume was reduced by 18% in the primary group; in the secondary group, it decreased by 14% (Fig 3, D) . Table IV shows the total number of implanted SMFMs, stent graft devices, and aortic branches covered. There were 30 SMFM devices used and four stent grafts among the 12 cases. There were 69 aortic branches covered during the endovascular repair with the following vessel distribution: brachiocephalic arteries (7), left common carotid arteries (7), left subclavian arteries (7), superior mesenteric arteries (12), celiac arteries (12), left renal arteries (12) , and right renal arteries (12) .
In general, blood flow accelerated along the narrowed true lumen regions as well as entering false lumen tears. The velocity fields corresponding to the 12 cases are shown in Fig 4, at peak systole (t ¼ 0.18 second) . Depicted red regions in the velocity field represent the accelerated flow; the blue velocity field marks the decelerated and turbulent flow.
The wall pressure distribution contour plot is shown in Fig 5 for all cases. It was noticed after treatment that pressure distribution blends along the true lumen because of the enlargement of the compressed regions, whereas the false lumen wall pressure was decreased by 6.23% 6 4.81% for the primary group (cases 1-7) and by 3.84% 6 2.59% for the secondary group (cases 8-12; Fig 6) . Along with the lumen pressure contour plots, the true and false lumen geometry remodeling effect at 1 year after last intervention is shown in Fig 5. The brain perfusion changes induced by SMFM through the carotid arteries, suprarenal arteries, and renal arteries were monitored. Fig 7, A shows the perfusion percentage increases for the primary and the secondary interventions. The primary SMFM treatment of the SCTBADs produced a higher median perfusion percentage increase by up to 35% 6 21% (P ¼ .0216) for the carotid arteries and 78% 6 32% (P ¼ .001) for the suprarenal arteries compared with the secondary group. The secondary group had greater renal perfusion increase by up to 124% 6 53% (P ¼ .011) than the primary group (55% 6 28%; P < .001).
The subgroup analysis monitored the carotid perfusion (Fig 7, B-D ; Table V ). The subgroup 1 (Fig 7, B) showed best carotid perfusion in the aortobi-iliac cases (16.6% 6 30.5%; P ¼ .004) because of SMFM spiral flow induction at the aortic bifurcation, whereas a perfusion decrease was found in the aortouni-iliac cases (À4.1% 6 7.5%; P ¼ .031). Positioning the proximal end of the SMFM stent in the ascending aorta had a greater impact on the carotid perfusion, increasing it by 42.1% 6 15% (P ¼ .003) vs 3.4% 6 7.8% (P ¼ .014) increase for the descending aorta (Fig 7, C) . In subgroup 3, the normal technique surpassed the PETTICOAT technique by increasing carotid perfusion up to 11.6% 6 25.4% (P < .001), as shown in Fig 7, D. 
DISCUSSION
Our study analyzed 12 cases of SCTBAD that were treated with the SMFM device. The uncovered multilayer stent technology has been used to treat peripheral, visceral, and aortic aneurysms. The SMFM is a selfexpandable mesh of cobalt alloy wires interconnected in five layers, extremely flexible with a low total porosity. Its design allows blood flow through the device mesh to maintain collateral branch patency while modulating turbulent flow to laminar within the device and the aneurysm sac. The laminar flow in the aneurysm reduces shear stress on the aneurysm wall and encourages an organized thrombus formation, thereby stabilizing aneurysm size and reducing risk of rupture. 16 During the follow-up period of the study, there were no complications reported, such as rupture or stent fractures, and no spinal or visceral ischemia, no cerebral vascular stroke, no lower limb ischemia, and no retrograde type A dissection. The maximum aortic diameter increased preoperatively to postoperatively because of device oversizing and slow elastic recoil of the SMFM structure over time, which generated radial expansion of the true lumen after delivery. As a clinical consequence, although the aortic wall was stretched by the SMFM, it was consolidated and supported in the same time by the device mesh, thus reducing the risk of a possible rupture. The changes in size for the true and false lumens were reported as mean volume increases and not as diameters because we believe volume size is a more representative way of monitoring changes in situations in which diameters do not change dramatically, whereas the false lumen length may change during the follow-up period.
The volume changes were statistically significant (P ¼ .023 for true lumen and P ¼ .003 for false lumen). The true lumen expanded the aortic stent diameter in the range of 30% to 80% among all cases. The shrinkage of the false lumen was seen in both treatment groups from 14% (secondary intervention) to 18% (primary intervention; Fig 3, D) .
With the use of CFD analysis, we investigated the blood flow dynamics in the patients treated with the SMFM to reveal how the device works in SCTBAD and if there are any complications associated with it, as with other devices. CFD analysis was previously employed in the study of SCTBAD by Cheng et al, 9 Shang et al, 7 and
Wan et al. 8 Our models had revealed matching results with those of Shang et al, 7 who showed that patients with aneurysmal degeneration had higher growth rate compared with those with stable aortic diameters. The predicted blood flow patterns in the preoperative state are in agreement with the predictions made by Cheng et al 9 and Wan et al 8 in terms of accelerated blood flow in the compressed true lumen and regions of flow recirculation in the false lumen (Fig 4) . Ten of the 12 cases had >10% decrease in the FLI, which made us conclude that the treatment can be regarded as efficient when such decrease for the FLI is noticed. This finding should be considered an important indicator threshold toward the healing of the SCTBADs. Complete thrombosis of the false lumen with aortic remodeling was observed in all cases studied because of the SMFM device's role in restoring a low elastic recoil to the aorta.
Despite the decrease of the FLI, the total aortic volume has increased in the majority of the cases. This is a result of the true lumen's dramatic expansion induced by the SMFM in a very short time, in contrast with the longterm false lumen volume reduction. The sudden increase in the total aortic volume may sound alarming at first sight, but the true lumen wall is supported by the SMFM and takes all the systemic pressure postoperatively while the false lumen wall is not subjected to high pressure any more, thus decreasing the risk of aortic rupture.
The predicted interaction between blood flow and the SMFM device represents new data, which is of great clinical value in considering this device for SCTBAD. The authors of this study believe that this is firsthand knowledge in assessing the effects of the SMFM device over the branch patency in SCTBAD. The outflows of each branch were monitored and compared after SMFM. Perfusion to the carotids, suprarenal arteries, and renal arteries was highly influenced by this device, with percentage increases from 35% to the carotids to 78% to the suprarenal arteries and 124% to the renal vessels. The renal artery perfusion increase, noticed in the secondary group, could be associated with the significant and immediate expansion of the true lumen due to the SMFM. The primary intervention, with the covered stent, failed to cut the flow to the false lumen, which allowed further false lumen increase and true lumen decrease, thus generating higher flow resistance in the true lumen. The increase in blood flow to the renal arteries represents a promising result that may benefit the patients with renal failure. Therefore, we hypothesize that the SMFM device can help enhance kidney perfusion for those patients.
The group in which the SMFM was solely used had better perfusion outcomes compared with the secondary group. The subgroup analysis revealed that the SMFM performed best in the aortobi-iliac dissections and surpassed the PETTICOAT TEVAR SMFM technique in terms of carotid perfusion.
The preoperative wall systolic pressure plots were in agreement with previous studies that reported higher pressure in the false lumen compared with the true lumen in patients with a large false lumen area. 17 The postoperative aortic wall pressure plots showed that the SMFM managed to blend the systemic pressure distribution from aortic root to the iliac bifurcation (Fig 5) . The idea of a single entry point and exit point does not hold anymore because of our observations of multiple entry and exit points along the length of the dissections studied.
This study assessed the hemodynamics at the systolic pressure between the true and false lumens and the SMFM device. The SMFM needs to cover from normal to normal aorta to stabilize the unstable aorta and to fix all the entry holes, and double or triple stenting is possible across any major side branch. It is a must to induce spiral flow at the distal aorta by phantom configuration of the SMFM or double hugging stents from the distal aortic SMFM to both common iliacs. When the SMFM is implanted in the total aorta, a low elastic recoil to the aorta is re-established and augmentation of the flow is to all spinal and major branches, which will aid in improving the patient's blood pressure and renal function. 10 Our CFD result documented a few important findings. First, the SMFM device worked in dissection cases in and out of instructions for use. Second, for maximum efficiency of this smart technology, it should be used on its own and not in a PETTICOAT configuration. Third, we witnessed that all aortic dissection patients had numerous holes, not a single entry and exit point. Fourth, the equalization in pressure between true lumen and false lumen allows rapid false lumen thrombosis as two parallel flow channels will always compete to the least resistance, which is the true SMFM lumen. Last, it allows full aortic stabilization without the fear of any major side branch occlusion. On the basis of our CFD analysis outcomes and the recently published study on clinical success by managing complex thoracoabdominal aortic disease with the SMFM, 18 we believe that SCTBAD should become the main indication for the SMFM device.
Study limitations. All subjects were subjected to the same inflow conditions, which were derived from the literature.
Clinical implications. The FLI was shown to have a critical role in monitoring the progress of SCTBAD because the effect of anatomic factors on aortic dissection is complex and difficult to reveal by the maximum aortic diameter alone. Perfusion of the aortic branches is increased after TEVAR. The SMFM may represent the primary option in treating SCTBAD while avoiding short-and long-term complications.
CONCLUSIONS
SMFM modulates the pressure in the false lumen, which promotes thrombus formation, and preserves patency of all aortic branches, thus reducing the incidence of the complicated dissections after TEVAR. SMFM induced the aortic remodeling process in patients with SCTBAD during 1-year follow-up with superior CFD outcomes. There is little consensus or data on how to manage chronic complicated dissection where the aorta has failed to remodel. The thickened and stiffened dissection flap makes management extremely difficult for those patients in whom the true lumen and branches are compromised or the false lumen has become increasingly aneurysmal, or both.
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The study by Stefanov et al offers some insight by investigating clinical outcomes and computational analysis on the same group of patients to study the efficacy of the Streamliner Multilayer Flow Modulator (SMFM; Cardiatis, Isnes, Belgium) for chronic complicated type B dissection. This small study involves 12 patients who were declined current endovascular techniques because of anatomical complexity and high-risk status. Selectively invited physicians performed heterogeneous SMFM procedures entered nonsequentially in a multicenter registry across the globe through an online platform. The registry lacked audit function because the data were received "as is" from participating sites.
What is incredible, despite the small number of patients, is that during the follow-up period of the study, no complications were reported, such as rupture or stent fractures, no spinal or visceral ischemia, no cerebral vascular stroke, no lower limb ischemia, and no retrograde type A dissection. Complete thrombosis of the false lumen with aortic remodeling was observed in all patients.
The mean maximum aortic diameter and volume increased after SMFM. Alarming at first sight, the authors have demonstrated that the true lumen wall is supported by the SMFM, which takes all the systemic pressure and that the false lumen wall is no longer subjected to high pressure, thus decreasing the risk of aortic rupture.
There was an increase in the mean true lumen volume (25%) and a reduction in the mean false lumen volume (16%). The false lumen index was not statistically different between the preoperative and postoperative states. The real value of SMFM may be to increase perfusion to the branch arteries with a demonstrated increase of 78% to suprarenal and to 124% to renal vessels, potentially increasing its role in preventing spinal, mesenteric, and renal ischemia.
The authors are to be commended for obtaining and comparing pathophysiologic data to impressive clinical outcomes. A larger data set, removal of selection bias, robust patient selection, and outcome reporting will add weight to the hypotheses proposed by the authors. Unfortunately, SMFM is burdened by its controversial history. SMFM was introduced as a potential "game-changing technology" but has yet to establish itself as a standard endovascular modality for the treatment of aortic aneurysms because of inconsistent results after years of trials.
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